Abstract
Chemotherapy-induced neuropathy is difficult to manage, and the pain associated with neuropathy is poorly responsive to gabapentin in a randomized trial. Duloxetine is the only drug that has been found to be effective in reducing pain from chemotherapy neuropathy. In this qualitative review, the use of pregabalin for chemotherapy-induced neuropathy is discussed including the rationale and pharmacological reasons why pregabalin should be considered in a large, randomized placebo-controlled trial.
Original language | English (US) |
---|---|
Pages (from-to) | 8845-8853 |
Number of pages | 9 |
Journal | Supportive Care in Cancer |
Volume | 30 |
Issue number | 11 |
DOIs | |
State | Published - Nov 2022 |
Keywords
- Alpha2dellta
- Calcium channel
- Chemotherapy
- Neuropathy
- Pain
- Pregabalin
ASJC Scopus subject areas
- Oncology